1980
Serum glycoproteins in cancer patients: First report of correlations with in vitro and in vivo parameters of cellular immunity
Baskies A, Chretien P, Weiss J, Makuch R, Beveridge R, Catalona W, Spiegel H. Serum glycoproteins in cancer patients: First report of correlations with in vitro and in vivo parameters of cellular immunity. Cancer 1980, 45: 3050-3060. PMID: 7388749, DOI: 10.1002/1097-0142(19800615)45:12<3050::aid-cncr2820451229>3.0.co;2-8.Peer-Reviewed Original ResearchConceptsDepressed cellular immunityLymphocyte reactivityCellular immunityCancer patientsAlpha 2 HS-glycoproteinAlbumin levelsTumor extentHS-glycoproteinVivo parametersLevels of haptoglobinLevels of APPSerum glycoprotein levelsSerum protein levelsSerum glycoproteinsOngoing trialsPreoperative patientsRegional tumorsSerum levelsImmune statusImmunologic functionSolid malignanciesNormal controlsPatientsGlycoprotein levelsPrimary site
1979
Improvements in circulating levels of immune-reactive proteins simultaneous with depression of thymus-dependent lymphocytes during radiation therapy for solid malignancies
Baskies A, Chretien P, Weiss J, Makuch R, Spiegel H. Improvements in circulating levels of immune-reactive proteins simultaneous with depression of thymus-dependent lymphocytes during radiation therapy for solid malignancies. International Journal Of Radiation Oncology • Biology • Physics 1979, 5: 67-68. DOI: 10.1016/0360-3016(79)91047-2.Peer-Reviewed Original Research